Option Care Health (OPCH) to Release Quarterly Earnings on Tuesday

Option Care Health (NASDAQ:OPCH) will likely be announcing its Q4 2025 results before the market opens on Tuesday, February 24th. Analysts expect Option Care Health to post earnings of $0.46 per share and revenue of $1.4633 billion for the quarter. Investors may review the information on the company’s upcoming Q4 2025 earning report for the latest details on the call scheduled for Tuesday, February 24, 2026 at 8:30 AM ET.

Option Care Health Stock Up 0.1%

OPCH opened at $35.69 on Friday. Option Care Health has a fifty-two week low of $24.24 and a fifty-two week high of $36.80. The firm has a market capitalization of $5.67 billion, a P/E ratio of 28.33, a PEG ratio of 2.13 and a beta of 0.84. The company’s 50-day moving average is $33.92 and its 200 day moving average is $30.40. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.56 and a quick ratio of 1.05.

Institutional Investors Weigh In On Option Care Health

Large investors have recently added to or reduced their stakes in the company. UMB Bank n.a. lifted its holdings in shares of Option Care Health by 23.5% in the fourth quarter. UMB Bank n.a. now owns 1,715 shares of the company’s stock worth $55,000 after buying an additional 326 shares in the last quarter. Wealthspire Advisors LLC lifted its stake in Option Care Health by 6.2% in the 4th quarter. Wealthspire Advisors LLC now owns 11,172 shares of the company’s stock worth $356,000 after purchasing an additional 648 shares in the last quarter. Mariner LLC boosted its holdings in Option Care Health by 7.1% in the 4th quarter. Mariner LLC now owns 10,060 shares of the company’s stock valued at $321,000 after purchasing an additional 663 shares during the period. Parkside Financial Bank & Trust grew its position in shares of Option Care Health by 9.1% during the 4th quarter. Parkside Financial Bank & Trust now owns 8,718 shares of the company’s stock valued at $278,000 after purchasing an additional 728 shares in the last quarter. Finally, Northwestern Mutual Wealth Management Co. increased its holdings in shares of Option Care Health by 84.9% in the third quarter. Northwestern Mutual Wealth Management Co. now owns 1,771 shares of the company’s stock worth $49,000 after purchasing an additional 813 shares during the period. Hedge funds and other institutional investors own 98.05% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have commented on the stock. Bank of America lifted their target price on shares of Option Care Health from $32.00 to $35.00 and gave the stock a “buy” rating in a research report on Tuesday, December 9th. National Bank Financial set a $37.00 price target on Option Care Health in a report on Tuesday, January 27th. Stephens raised Option Care Health to a “strong-buy” rating in a research report on Thursday, December 11th. TD Cowen reaffirmed a “hold” rating on shares of Option Care Health in a research report on Tuesday, January 27th. Finally, Deutsche Bank Aktiengesellschaft boosted their price target on shares of Option Care Health from $31.00 to $36.00 and gave the stock a “buy” rating in a report on Tuesday, December 9th. One equities research analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Option Care Health presently has a consensus rating of “Moderate Buy” and a consensus target price of $37.58.

Option Care Health Company Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.